A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One looming question: Will it be affordable for lower resource countries?
Gilead’s lenacpavir, la ong-acting HIV capsid inhibitor shows 96–100% efficacy in phase 3 trials and aims to expand access worldwide through regulatory filings and support…
CBS News 24/7 is the premier anchored streaming news service from CBS News and Stations.
Contagion® is a fully integrated news resource for practitioners and specialists to assist with the identification, diagnosis, treatment, and prevention of infectious diseases.
The COVID-19 variant that may be driving a recent rise in cases in some parts of the world has earned a new nickname: “razor blade…
WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect…
It’s MAHA fantasy season, so let’s take a look at this year’s rookie class. Which preventable disease will start killing children first?
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 Since late April, an infectious diseases specialist at Stanford University and his colleagues have been volunteering their time on a…
Amid the dismantling and re-structuring of U.S. foreign assistance, policymakers can apply lessons from a decade of DREAMS programming to avert a resurgent HIV epidemic…
Microorganisms, including multidrug-resistant organisms (MDROs), can persist on hospital surfaces, posing significant health risks. Patient privacy curtains (PPCs) are particularly vulnerable due to their porous…
